carbon monoxide has been researched along with Parkinson Disease in 11 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study evaluated the association of carbon monoxide intoxication (COI) with Parkinson disease (PD)." | 7.81 | Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study. ( Chou, MC; Kao, CH; Lai, CY; Lin, CL, 2015) |
| "The present study evaluated the association of carbon monoxide intoxication (COI) with Parkinson disease (PD)." | 3.81 | Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study. ( Chou, MC; Kao, CH; Lai, CY; Lin, CL, 2015) |
| "Respiratory dysfunction in Parkinson's disease (PD) is common and associated with increased hospital admission and mortality rates." | 3.01 | A systematic review and meta-analysis of respiratory dysfunction in Parkinson's disease. ( Blake, C; Lennon, O; McMahon, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| McMahon, L | 1 |
| Blake, C | 1 |
| Lennon, O | 1 |
| Jo, S | 1 |
| Kim, YJ | 1 |
| Park, KW | 1 |
| Hwang, YS | 1 |
| Lee, SH | 1 |
| Kim, BJ | 1 |
| Chung, SJ | 1 |
| Shefa, U | 1 |
| Yeo, SG | 1 |
| Kim, MS | 1 |
| Song, IO | 1 |
| Jung, J | 1 |
| Jeong, NY | 1 |
| Huh, Y | 1 |
| Lai, CY | 1 |
| Chou, MC | 1 |
| Lin, CL | 1 |
| Kao, CH | 1 |
| BREUIL, M | 1 |
| STECHER, W | 1 |
| DEREUX, J | 1 |
| CATOIR, J | 1 |
| Cuadrado, A | 1 |
| Rojo, AI | 1 |
| Schipper, HM | 1 |
| Liberman, A | 1 |
| Stopa, EG | 1 |
| Riedl, AG | 1 |
| Watts, PM | 1 |
| Brown, CT | 1 |
| Jenner, P | 1 |
| McGeer, PL | 1 |
4 reviews available for carbon monoxide and Parkinson Disease
| Article | Year |
|---|---|
A systematic review and meta-analysis of respiratory dysfunction in Parkinson's disease.
Topics: Carbon Monoxide; Case-Control Studies; Cough; Disease Progression; Dyspnea; Humans; Lung Volume Meas | 2023 |
Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair.
Topics: Alzheimer Disease; Carbon Monoxide; Cardiovascular System; Gasotransmitters; Humans; Hydrogen Sulfid | 2017 |
Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections.
Topics: Alzheimer Disease; Animals; Biliverdine; Brain; Carbon Monoxide; Central Nervous System Infections; | 2008 |
P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease.
Topics: Animals; Basal Ganglia; Carbon Monoxide; Carbon Monoxide Poisoning; Cytochrome P-450 Enzyme System; | 1999 |
7 other studies available for carbon monoxide and Parkinson Disease
| Article | Year |
|---|---|
Association of NO2 and Other Air Pollution Exposures With the Risk of Parkinson Disease.
Topics: Adult; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cohort Studies; Female; Humans; Male; M | 2021 |
Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study.
Topics: Adult; Age Factors; Aged; Carbon Monoxide; Cohort Studies; Comorbidity; Female; Humans; Incidence; M | 2015 |
[Apropos of an extrapyramidal parkinsonian syndrome connected with a chronic carbon monoxide poisoning].
Topics: Air Pollutants; Basal Ganglia Diseases; Carbon Monoxide; Carbon Monoxide Poisoning; Disease; Extrapy | 1962 |
[Case of injury of the central nervous system after carbon monoxide poisoning].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Central Nervous System; Humans; Parkinson Disease; Perso | 1952 |
[Two complications after carbon monoxide poisoning; transitory Parkinson's syndrome with inertia and mutism and chronic chorea].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Chorea; Huntington Disease; Mutism; Parkinson Disease | 1952 |
Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.
Topics: Aged; Aged, 80 and over; Astrocytes; Biomarkers; Carbon Monoxide; Dopamine; Glial Fibrillary Acidic | 1998 |
Tyrosine hydroxylase and parkinsonism.
Topics: Animals; Brain; Carbon Monoxide; Catecholamines; Dopamine; Haplorhini; Humans; Manganese; Mixed Func | 1971 |